120 related articles for article (PubMed ID: 9704811)
1. Mircette: a novel oral contraceptive. Introduction.
Speroff L
Am J Obstet Gynecol; 1998 Jul; 179(1):S1. PubMed ID: 9704811
[No Abstract] [Full Text] [Related]
2. [Clinical study of the low dose oral contraceptive novynette].
Uchikova E; Milchev N
Akush Ginekol (Sofiia); 2003; 42(4):15-6. PubMed ID: 14577362
[TBL] [Abstract][Full Text] [Related]
3. [Novynette--trends in contraception at the beginning of the new millennium].
Ivanov S; Sigridov I
Akush Ginekol (Sofiia); 2004; 43 Suppl 2():30-2. PubMed ID: 15518273
[No Abstract] [Full Text] [Related]
4. An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group.
Am J Obstet Gynecol; 1998 Jul; 179(1):S2-8. PubMed ID: 9704812
[TBL] [Abstract][Full Text] [Related]
5. Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval.
Killick SR; Fitzgerald C; Davis A
Am J Obstet Gynecol; 1998 Jul; 179(1):S18-24. PubMed ID: 9704814
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of two monophase oral contraceptives with desogestrel].
Uchikova E; Milchev N; Markova D; Batashki I; Gŭrova A
Akush Ginekol (Sofiia); 2007; 46(2):18-21. PubMed ID: 17469446
[TBL] [Abstract][Full Text] [Related]
7. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
Vree ML; Schmidt J
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the monophase oral contraceptive combination with 20 ug ethinyl estradiol/150 ug desogestrel on haemostasis].
Uchikova E; Milchev N; Terzhumanov R; Markova D
Akush Ginekol (Sofiia); 2004; 43(4):29-32. PubMed ID: 15318540
[TBL] [Abstract][Full Text] [Related]
9. Acne treatment with a new estroprogestinic biphasic combination containing desogestrel.
Falsetti L
Acta Eur Fertil; 1991; 22(5):283-6. PubMed ID: 1845752
[No Abstract] [Full Text] [Related]
10. The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands.
Roumen FJ; op ten Berg MM; Hoomans EH
Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):14-22. PubMed ID: 16546812
[TBL] [Abstract][Full Text] [Related]
11. [Effect of low-dose oral contraceptive regulon-Gedeon Richter on some hemostatic variables].
Uchikova E; Ledzhev I; Milchev N; Tsvetkova T
Akush Ginekol (Sofiia); 2004; 43(2):58-62. PubMed ID: 15185533
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
Vartiainen M; de Gezelle H; Broekmeulen CJ
Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):46-53. PubMed ID: 11334476
[TBL] [Abstract][Full Text] [Related]
13. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
14. [Axillary vein thrombosis in a young woman with a contraceptive ring. Prothrombin gene mutation a possible connection].
Samuelsson E; Hultdin J; Groth K; Hedenmalm K
Lakartidningen; 2007 Jan 10-16; 104(1-2):32-4. PubMed ID: 17323737
[No Abstract] [Full Text] [Related]
15. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
[TBL] [Abstract][Full Text] [Related]
16. Quartette: an ascending-dose, extended-cycle oral contraceptive.
Med Lett Drugs Ther; 2013 Jul; 55(1420):54-5. PubMed ID: 23836372
[No Abstract] [Full Text] [Related]
17. Estradiol + nomegestrol. Oral contraceptive claimed to be more natural, but presenting no obvious advantages.
Prescrire Int; 2012 Dec; 21(133):292. PubMed ID: 23373095
[TBL] [Abstract][Full Text] [Related]
18. [Clarification concerning NuvaRing].
Jonsson M
Lakartidningen; 2007 Jan 31-Feb 6; 104(5):355. PubMed ID: 17328363
[No Abstract] [Full Text] [Related]
19. Effects of an oral contraceptive combination containing 0.150 mg desogestrel plus 0.020 mg ethinyl estradiol on healthy premenopausal women.
de Aloysio D; Mauloni M; Roncuzzi A; Altieri P; Bottiglioni F; Trossarelli GF; Fanizza G; Covelli A
Arch Gynecol Obstet; 1993; 253(1):15-9. PubMed ID: 8328816
[TBL] [Abstract][Full Text] [Related]
20. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
